drugset / Trial / NCT02354612
Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial
Summary
Open-label, continuation study
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carotuximab | Monoclonal antibody | — | — |
| Background | Axitinib | Small molecule | — | — |
| Background | Bevacizumab | Monoclonal antibody | — | — |
| Background | Capecitabine | Small molecule | — | — |
| Background | Pazopanib | Small molecule | — | — |